Earnings8-K
Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
VCEL
Vericel Corporation
A biopharmaceutical company that grows patients' own cells into treatments for sports injuries and severe burns. Its flagship product, MACI, repairs torn knee cartilage, while Epicel grows a patient's skin cells into a permanent graft for large burns. Founded in 1989 as Aastrom Biosciences, it became Vericel in 2014 after buying Sanofi's cell-therapy business. The name plays on the word "cell," and thousands of burn patients have been treated with Epicel.
CUSIP: 92346J108HealthcareUS1 holder